Dragonfly Energy (Nasdaq: DFLI) Powers Highway Transport’s Fleet with Battle Born All-Electric APUs

Dragonfly Energy’s Battle Born All-Electric APU The Battle Born All-Electric APU Side Box Highway Transport, a North American leader in liquid chemical transportation, will begin integrating the Battle Born All-Electric APU into their fleet. The Battle Born All-Electric APU offers a comprehensive lithium iron phosphate (“LiFePO4”) based power solution that is expected to reduce Highway […]

Greenlane NASDAQ:GNLN Announces Non-Binding Letter of Intent to be the Exclusive Distributor in the U.S. of Safety Strips, Inc.’s Fentanyl, Xylazine and Drink Spike Detection Test Strips

High-sensitivity test strips offer powerful detection capability for the current and growing opiate crisis Combining Greenlane’s industry leading omnichannel distribution platform with Safety Strips affordable and highly accurate ISO certified test strips to help prevent opioid-related deaths BOCA RATON, FL / ACCESSWIRE / August 12, 2024 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), one […]

NanoViricides (NYSE American:NNVC) Provides an Update on Its Clinical Program and Strategy – NV-387 Could be As Revolutionary as Antibiotics

SHELTON, CT / ACCESSWIRE / August 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, is providing an update on its clinical program and strategy in this letter to investors. NanoViricides is developing a unique direct-acting antiviral drug that mimics the host cell and thereby is designed […]

Tiziana Life Sciences (Nasdaq: TLSA) Granted FDA Fast Track Designation

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its intranasal […]

Sadot Group (NASDAQ:SDOT) Announces Sale of Superfit Foods

FORT WORTH, TX / ACCESSWIRE / August 6, 2024 / Sadot Group Inc. (NASDAQ:SDOT) (“Sadot” or the “Company”) today announced the sale of one of its restaurant assets, Superfit Foods LLC, a subscription-based meal prep concept located in Orange Park, FL, servicing the Jacksonville market. Michael Roper, CEO of Sadot Group, stated, “We are pleased to […]

Sadot Group Inc. (NASDAQ:SDOT) Announces Second Quarter 2024 Conference Call

FORT WORTH, TX / ACCESSWIRE / August 7, 2024 / Sadot Group Inc. (NASDAQ:SDOT) (the “Sadot Group” or the “Company”), an emerging player in the global food supply chain sector, today announced that the Company plans to file its second quarter results ending, June 30, 2024, on Tuesday August 13th, 2024. Sadot Group will then follow […]

Greenlane’s (NASDAQ:GNLN) Vapor.com Named to USA Today’s List of “America’s Top Online Retail Shops” in Recent Survey

BOCA RATON, FL / ACCESSWIRE / August 6, 2024 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, announced that its online shop, Vapor.com, was included on USA Today’s list of America’s Top Online Shops. In partnership with the data analysis company […]

Inspire Veterinary Partners (NASDAQ:IVP) Reaffirms Plans to Accelerate Acquisition and Growth Strategy Following Closing of Recent Public Offering

Strategy includes multiple paths for long-term growth in the economically resilient pet health and wellness marketplace Company to leverage Enterprise-wide systems and tools which were enhanced over the last six quarters New phases of growth will be aimed at existing and new verticals in the pet health sector VIRGINIA BEACH, VA / ACCESSWIRE / August […]

Longeveron® (NASDAQ: LGVN) to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024

MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will report second quarter 2024 financial results and provide a business update on Wednesday, August 14, 2024 after the U.S. financial markets close. The Company will […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.